ACQUIREDT+7
Ashokkumar Vijaysinh Barot
Senores Pharmaceuticals Limited · NSE
Filed 17 Aug 2026SEBI SASTview source
Swapnil Jatin Shah
Investor
₹16.00 Cr
1,97,000 sh
Ashokbhai Vijaysinh Barot
Investor
₹9.99 Cr
1,40,086 sh
Sangeeta Mukur Barot
Investor
₹4.99 Cr
61,500 sh
Viraj Ashokkumar Barot
Investor
₹4.02 Cr
49,500 sh
Chetan Bipinchandra Shah
Investor
₹3.57 L
1,000 sh
Dhruvalben V Shah
Investor
₹2.72 L
500 sh
Vinodkumar Gandalal Shah
Investor
₹2.35 L
300 sh
Amee Chetan Shah
Investor
₹1.96 L
300 sh
Pratik Sureshkumar Thakkar HUF
Investor
₹1.56 L
550 sh
Ashokkumar Vijaysinh Barot
Investor
₹0
30,000 sh
FIIs raised their stake +3.0pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Ashokkumar Vijaysinh Barot
Senores Pharmaceuticals Limited · NSE
Dhananjay Ashokkumar Barot
Senores Pharmaceuticals Limited · NSE
−30,000 sh
Ashokkumar Vijaysinh Barot
Senores Pharmaceuticals Limited · NSE
+30,000 sh · ₹0
Dhananjay Ashokkumar Barot
Senores Pharmaceuticals Limited · NSE
−30,000 sh · ₹0
Sangeeta Mukur Barot
Senores Pharmaceuticals Limited · NSE
+61,500 sh · ₹4.99 Cr
Swapnil Jatin Shah
Senores Pharmaceuticals Limited · NSE
+1,97,000 sh · ₹16.00 Cr
Ashokbhai Vijaysinh Barot
Senores Pharmaceuticals Limited · NSE
+1,23,000 sh · ₹9.99 Cr
Viraj Ashokkumar Barot
Senores Pharmaceuticals Limited · NSE
+49,500 sh · ₹4.02 Cr
Renosen Pharmaceuticals Private Limited
Senores Pharmaceuticals Limited · NSE
+7,39,000 sh · ₹60.01 Cr
Dhruvalben V Shah
Senores Pharmaceuticals Limited · NSE
+350 sh · ₹2.72 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
29 announcements on record for this company.
Promoter holding by quarter: Jun 2025 45.8%, Sep 2025 45.8%, Dec 2025 45.8%, Mar 2026 45.8%. Dec 2024, Mar 2025: no filing.
FII
— +0.3pp
FII holding by quarter: Jun 2025 3.7%, Sep 2025 4.3%, Dec 2025 3.4%, Mar 2026 3.6%. Dec 2024, Mar 2025: no filing.
DII
— +0.3pp
DII holding by quarter: Jun 2025 9.5%, Sep 2025 8.6%, Dec 2025 9.3%, Mar 2026 9.6%. Dec 2024, Mar 2025: no filing.
MF
— +0.2pp
MF holding by quarter: Jun 2025 3.0%, Sep 2025 3.5%, Dec 2025 4.9%, Mar 2026 5.1%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 45.8%, Sep 2025 45.8%, Dec 2025 45.8%, Mar 2026 45.8%. Dec 2024, Mar 2025: no filing.
FII
— +0.3pp
FII holding by quarter: Jun 2025 3.7%, Sep 2025 4.3%, Dec 2025 3.4%, Mar 2026 3.6%. Dec 2024, Mar 2025: no filing.
DII
— +0.3pp
DII holding by quarter: Jun 2025 9.5%, Sep 2025 8.6%, Dec 2025 9.3%, Mar 2026 9.6%. Dec 2024, Mar 2025: no filing.
MF
— +0.2pp
MF holding by quarter: Jun 2025 3.0%, Sep 2025 3.5%, Dec 2025 4.9%, Mar 2026 5.1%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
29 announcements on record for this company.